questionsmedicales.fr
Qualité, accès, évaluation des soins de santé
Prestations des soins de santé
Attitude envers la santé
Mésusage des services de santé
Surmédicalisation
Traitement excessif
Polypharmacie
Polypharmacie : Questions médicales fréquentes
Diagnostic
5
Polypharmacie
Médicaments
Évaluation des médicaments
Outils d'évaluation
Interactions médicamenteuses
Médicaments
Effets indésirables
Hospitalisation
Polypharmacie
Professionnels de santé
Pharmaciens
Médecins
Personnes âgées
Comorbidités
Polypharmacie
Symptômes
5
Confusion
Somnolence
Chutes
Troubles cognitifs
Mémoire
Concentration
Douleurs abdominales
Douleurs musculaires
Interactions médicamenteuses
Nausées
Vertiges
Éruptions cutanées
Hypertension
Diabète
Maladies chroniques
Prévention
5
Communication
Prévention
Professionnels de santé
Bilan de santé
Évaluation des médicaments
Prévention
Éducation des patients
Médicaments
Prévention
Applications de santé
Suivi des médicaments
Interactions médicamenteuses
Gériatrie
Optimisation des traitements
Prévention
Traitements
5
Gestion des médicaments
Réévaluation
Prescriptions
Gérontologie
Pharmaciens
Médecins
Thérapie physique
Approches non médicamenteuses
Polypharmacie
Réduction des médicaments
Évaluation
Arrêt progressif
Médicaments génériques
Coûts des médicaments
Évaluation
Complications
5
Hospitalisations
Chutes
Interactions médicamenteuses
Accidents
Personnes âgées
Polypharmacie
Interactions médicamenteuses
Effets indésirables
Hospitalisations
Qualité de vie
Effets secondaires
Inconfort
Gestion des médicaments
Complications
Réversibilité
Facteurs de risque
5
Âge avancé
Comorbidités
Coordination des soins
Médecins
Prescriptions multiples
Polypharmacie
Maladies chroniques
Traitements
Polypharmacie
Éducation
Gestion des médicaments
Polypharmacie
Soins à domicile
Gestion des médicaments
Polypharmacie
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Polypharmacie : Questions médicales les plus fréquentes",
"headline": "Polypharmacie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Polypharmacie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-01",
"dateModified": "2026-07-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Polypharmacie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Traitement excessif",
"url": "https://questionsmedicales.fr/mesh/D000088922",
"about": {
"@type": "MedicalCondition",
"name": "Traitement excessif",
"code": {
"@type": "MedicalCode",
"code": "D000088922",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N05.300.150.395.450.188"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Polypharmacie",
"alternateName": "Polypharmacy",
"code": {
"@type": "MedicalCode",
"code": "D019338",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Michael J Schuh",
"url": "https://questionsmedicales.fr/author/Michael%20J%20Schuh",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Diana Sherifali",
"url": "https://questionsmedicales.fr/author/Diana%20Sherifali",
"affiliation": {
"@type": "Organization",
"name": "McMaster Evidence Review and Synthesis Team, McMaster University, 1280 Main St. W., McMaster Innovation Park, Room 207A, Hamilton, Ontario, L8S 4K1, Canada; School of Nursing, Faculty of Health Sciences, McMaster University, Health Sciences Centre Room HSC-3N25F, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada. Electronic address: dsherif@mcmaster.ca."
}
},
{
"@type": "Person",
"name": "Larkin Lamarche",
"url": "https://questionsmedicales.fr/author/Larkin%20Lamarche",
"affiliation": {
"@type": "Organization",
"name": "McMaster University, Dept. of Family Medicine DBHSC, 5th Floor 100 Main St West, Hamilton,Ontario L8P 1H6, Canada. Electronic address: lamarche@mcmaster.ca."
}
},
{
"@type": "Person",
"name": "Lorenz Van der Linden",
"url": "https://questionsmedicales.fr/author/Lorenz%20Van%20der%20Linden",
"affiliation": {
"@type": "Organization",
"name": "Pharmacy Department, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. lorenz.vanderlinden@uzleuven.be."
}
},
{
"@type": "Person",
"name": "Jos Tournoy",
"url": "https://questionsmedicales.fr/author/Jos%20Tournoy",
"affiliation": {
"@type": "Organization",
"name": "Department of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Polypharmacy in Older Patients.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39475037",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12968/hmed.2024.0388"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deprescribing in older adults with polypharmacy.",
"datePublished": "2024-05-07",
"url": "https://questionsmedicales.fr/article/38719530",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmj-2023-074892"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Polypharmacy and medication review in the context of prehabilitation].",
"datePublished": "2023-09-08",
"url": "https://questionsmedicales.fr/article/37682348",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00120-023-02174-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Interventions to improve the appropriate use of polypharmacy for older people.",
"datePublished": "2023-10-11",
"url": "https://questionsmedicales.fr/article/37818791",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD008165.pub5"
}
},
{
"@type": "ScholarlyArticle",
"name": "COVID-19 in Relation to Polypharmacy and Immunization (2020-2024).",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39459868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/v16101533"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Qualité, accès, évaluation des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D017530"
},
{
"@type": "ListItem",
"position": 3,
"name": "Prestations des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D003695"
},
{
"@type": "ListItem",
"position": 4,
"name": "Attitude envers la santé",
"item": "https://questionsmedicales.fr/mesh/D001294"
},
{
"@type": "ListItem",
"position": 5,
"name": "Mésusage des services de santé",
"item": "https://questionsmedicales.fr/mesh/D006300"
},
{
"@type": "ListItem",
"position": 6,
"name": "Surmédicalisation",
"item": "https://questionsmedicales.fr/mesh/D000069342"
},
{
"@type": "ListItem",
"position": 7,
"name": "Traitement excessif",
"item": "https://questionsmedicales.fr/mesh/D000088922"
},
{
"@type": "ListItem",
"position": 8,
"name": "Polypharmacie",
"item": "https://questionsmedicales.fr/mesh/D019338"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Polypharmacie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Polypharmacie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-25",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Polypharmacie",
"description": "Comment diagnostiquer la polypharmacie ?\nQuels outils aident au diagnostic ?\nQuels signes indiquent une polypharmacie ?\nQui peut diagnostiquer la polypharmacie ?\nLa polypharmacie est-elle courante chez les personnes âgées ?",
"url": "https://questionsmedicales.fr/mesh/D019338#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Polypharmacie",
"description": "Quels symptômes peuvent résulter de la polypharmacie ?\nComment la polypharmacie affecte-t-elle la cognition ?\nLa polypharmacie peut-elle causer des douleurs ?\nQuels effets secondaires sont fréquents ?\nLa polypharmacie peut-elle aggraver des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D019338#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Polypharmacie",
"description": "Comment prévenir la polypharmacie ?\nLes bilans de santé réguliers aident-ils ?\nL'éducation des patients est-elle importante ?\nLes applications de santé aident-elles ?\nLes consultations gériatriques sont-elles utiles ?",
"url": "https://questionsmedicales.fr/mesh/D019338#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Polypharmacie",
"description": "Comment gérer la polypharmacie ?\nQuels professionnels aident à la gestion ?\nY a-t-il des alternatives à la polypharmacie ?\nComment réduire le nombre de médicaments ?\nLes médicaments génériques aident-ils ?",
"url": "https://questionsmedicales.fr/mesh/D019338#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Polypharmacie",
"description": "Quelles complications peuvent survenir ?\nLa polypharmacie augmente-t-elle le risque d'accidents ?\nQuels sont les risques d'interactions médicamenteuses ?\nLa polypharmacie peut-elle affecter la qualité de vie ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D019338#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Polypharmacie",
"description": "Quels sont les facteurs de risque de la polypharmacie ?\nLe nombre de médecins influence-t-il la polypharmacie ?\nLes maladies chroniques sont-elles un facteur de risque ?\nLe manque d'éducation sur les médicaments est-il un risque ?\nLes soins à domicile augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D019338#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la polypharmacie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen des prescriptions et l'historique médical du patient."
}
},
{
"@type": "Question",
"name": "Quels outils aident au diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des outils comme les listes de vérification de médicaments et les logiciels d'interaction peuvent aider."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une polypharmacie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des effets secondaires fréquents ou des hospitalisations répétées peuvent indiquer la polypharmacie."
}
},
{
"@type": "Question",
"name": "Qui peut diagnostiquer la polypharmacie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médecins, pharmaciens et autres professionnels de santé peuvent diagnostiquer la polypharmacie."
}
},
{
"@type": "Question",
"name": "La polypharmacie est-elle courante chez les personnes âgées ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la polypharmacie est fréquente chez les personnes âgées en raison de comorbidités."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent résulter de la polypharmacie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la confusion, la somnolence ou des chutes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment la polypharmacie affecte-t-elle la cognition ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des troubles cognitifs, y compris des problèmes de mémoire et de concentration."
}
},
{
"@type": "Question",
"name": "La polypharmacie peut-elle causer des douleurs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions médicamenteuses peuvent provoquer des douleurs abdominales ou musculaires."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires sont fréquents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires fréquents incluent des nausées, des vertiges et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "La polypharmacie peut-elle aggraver des maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aggraver des maladies chroniques comme l'hypertension ou le diabète."
}
},
{
"@type": "Question",
"name": "Comment prévenir la polypharmacie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne communication entre patients et professionnels de santé."
}
},
{
"@type": "Question",
"name": "Les bilans de santé réguliers aident-ils ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers permettent d'évaluer la nécessité des médicaments prescrits."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur leurs médicaments et leurs effets est crucial pour la prévention."
}
},
{
"@type": "Question",
"name": "Les applications de santé aident-elles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines applications aident à suivre les médicaments et à éviter les interactions."
}
},
{
"@type": "Question",
"name": "Les consultations gériatriques sont-elles utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent d'optimiser les traitements chez les personnes âgées et de prévenir la polypharmacie."
}
},
{
"@type": "Question",
"name": "Comment gérer la polypharmacie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique la réévaluation régulière des médicaments et l'ajustement des prescriptions."
}
},
{
"@type": "Question",
"name": "Quels professionnels aident à la gestion ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médecins, pharmaciens et gérontologues jouent un rôle clé dans la gestion de la polypharmacie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des alternatives à la polypharmacie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des approches non médicamenteuses comme la thérapie physique peuvent être envisagées."
}
},
{
"@type": "Question",
"name": "Comment réduire le nombre de médicaments ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réduction peut se faire par l'évaluation des médicaments non essentiels et l'arrêt progressif."
}
},
{
"@type": "Question",
"name": "Les médicaments génériques aident-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les médicaments génériques peuvent réduire les coûts, mais nécessitent une évaluation prudente."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des hospitalisations, des chutes et des interactions graves."
}
},
{
"@type": "Question",
"name": "La polypharmacie augmente-t-elle le risque d'accidents ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle augmente le risque d'accidents, notamment chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'interactions médicamenteuses ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les interactions peuvent entraîner des effets indésirables graves, voire des hospitalisations."
}
},
{
"@type": "Question",
"name": "La polypharmacie peut-elle affecter la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut réduire la qualité de vie en augmentant les effets secondaires et l'inconfort."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec une gestion appropriée des médicaments."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la polypharmacie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, la présence de plusieurs maladies et le manque de coordination des soins."
}
},
{
"@type": "Question",
"name": "Le nombre de médecins influence-t-il la polypharmacie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, consulter plusieurs médecins augmente le risque de prescriptions multiples et de polypharmacie."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies chroniques nécessitent souvent plusieurs traitements, augmentant le risque de polypharmacie."
}
},
{
"@type": "Question",
"name": "Le manque d'éducation sur les médicaments est-il un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un manque d'éducation peut conduire à une mauvaise gestion des médicaments et à la polypharmacie."
}
},
{
"@type": "Question",
"name": "Les soins à domicile augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les soins à domicile peuvent parfois mener à une gestion inappropriée des médicaments."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 20/07/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Publications dans "Polypharmacie" :
2 publications dans cette catégorie
Affiliations :
McMaster Evidence Review and Synthesis Team, McMaster University, 1280 Main St. W., McMaster Innovation Park, Room 207A, Hamilton, Ontario, L8S 4K1, Canada; School of Nursing, Faculty of Health Sciences, McMaster University, Health Sciences Centre Room HSC-3N25F, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada. Electronic address: dsherif@mcmaster.ca.
Publications dans "Polypharmacie" :
2 publications dans cette catégorie
Affiliations :
McMaster University, Dept. of Family Medicine DBHSC, 5th Floor 100 Main St West, Hamilton,Ontario L8P 1H6, Canada. Electronic address: lamarche@mcmaster.ca.
Publications dans "Polypharmacie" :
2 publications dans cette catégorie
Affiliations :
Pharmacy Department, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. lorenz.vanderlinden@uzleuven.be.
Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, Leuven, Belgium. lorenz.vanderlinden@uzleuven.be.
Publications dans "Polypharmacie" :
2 publications dans cette catégorie
Affiliations :
Department of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium.
Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Publications dans "Polypharmacie" :
2 publications dans cette catégorie
Affiliations :
Division of General Dentistry, Department of Restorative Dental Sciences, University of Florida College of Dentistry, 1395 Center Drive, PO Box 100415, Gainesville, FL 32610-0415, USA. Electronic address: asoto@dental.ufl.edu.
Publications dans "Polypharmacie" :
2 publications dans cette catégorie
Affiliations :
University of Florida Health Science Center Libraries, 1600 Southwest Archer Road, PO Box 100206, Gainesville, FL 32610, USA.
Publications dans "Polypharmacie" :
1 publication dans cette catégorie
Affiliations :
Department of Internal Medicine, West Los Angeles Medical Center, CA.
Publications dans "Polypharmacie" :
1 publication dans cette catégorie
Affiliations :
Department of Internal Medicine, West Los Angeles Medical Center, CA.
Publications dans "Polypharmacie" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Science, Kaiser Permanente School of Medicine, Pasadena, CA.
Publications dans "Polypharmacie" :
1 publication dans cette catégorie
Affiliations :
Department of Family Medicine, Panorama City Medical Center, CA.
Publications dans "Polypharmacie" :
1 publication dans cette catégorie
Affiliations :
Department of Geriatrics, Palliative Medicine, and Continuing Care, Los Angeles Medical Center, CA.
Publications dans "Polypharmacie" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, South Bay Medical Center, Harbor City, CA.
Publications dans "Polypharmacie" :
1 publication dans cette catégorie
Affiliations :
Department of Internal Medicine, Los Angeles Medical Center, CA.
Publications dans "Polypharmacie" :
1 publication dans cette catégorie
Affiliations :
Department of Integrated Behavioral Health, Los Angeles Medical Center, CA.
Urgent Care Division, Los Angeles Medical Center, CA.
Publications dans "Polypharmacie" :
1 publication dans cette catégorie
Affiliations :
Department of Psychiatry, Panorama Medical Center, CA.
Publications dans "Polypharmacie" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiology, Baldwin Park Medical Center, CA.
Publications dans "Polypharmacie" :
1 publication dans cette catégorie
Affiliations :
Department of Physical Medicine and Rehabilitation, Baldwin Park Medical Center, CA.
Publications dans "Polypharmacie" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Baldwin Park Medical Center, CA.
Publications dans "Polypharmacie" :
1 publication dans cette catégorie
Affiliations :
Department of Geriatrics, Kaiser Permanente Southern California, Pasadena, CA.
Publications dans "Polypharmacie" :
Polypharmacy is common among older people and is associated with multiple adverse outcomes. Assessing whether it is appropriate or inappropriate for an individual is more informative than relying on a...
Polypharmacy is common in older adults and is associated with adverse drug events, cognitive and functional impairment, increased healthcare costs, and increased risk of frailty, falls, hospitalizatio...
Against the background of typical geriatric multimorbidity and with the particular vulnerability of geriatric patients, polypharmacy deserves special attention. In accordance with the guidelines, medi...
Inappropriate polypharmacy is a particular concern in older people and is associated with negative health outcomes. Choosing the best interventions to improve appropriate polypharmacy is a priority, s...
To assess the effects of interventions, alone or in combination, in improving the appropriate use of polypharmacy and reducing medication-related problems in older people....
We searched CENTRAL, MEDLINE, Embase, CINAHL and two trials registers up until 13 January 2021, together with handsearching of reference lists to identify additional studies. We ran updated searches i...
For this update, we included randomised trials only. Eligible studies described interventions affecting prescribing aimed at improving appropriate polypharmacy (four or more medicines) in people aged ...
Four review authors independently reviewed abstracts of eligible studies, and two authors extracted data and assessed the risk of bias of the included studies. We pooled study-specific estimates, and ...
We identified 38 studies, which includes an additional 10 in this update. The included studies consisted of 24 randomised trials and 14 cluster-randomised trials. Thirty-six studies examined complex, ...
It is unclear whether interventions to improve appropriate polypharmacy resulted in clinically significant improvement. Since the last update of this review in 2018, there appears to have been an incr...
Observational studies reported worse COVID-19 evolution in relation to polypharmacy and reductions in COVID-19 hospital admissions and death in patients receiving chronic antihistamine treatment. The ...
COVID-19 admissions to the Hospital of Terrassa (11 March 2020-28 August 2024 (n = 1457), from the integral Consorci Sanitari de Terrassa population (n = 167,386 people) were studied. Age, gender, the...
After 5 May 2023, 291 patients (54% females) required COVID hospitalization. Of these, 39% received >8 nT (23% receiving 5-7 nT), 70.2% were >70 years, and 93.4% survived. In total, 12% of patients ad...
Patients > 70 years who receive ≥5 nT, without prior COVID-19 infections, should be the priority for prevention, with updated vaccination and early treatments to reduce hospitalizations....
The UK population is ageing rapidly, a trend that is likely to continue due to improvements in chronic disease management and increased life expectancy. Comorbidities, including frailty, become increa...
Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are chronic, progressive inflammatory diseases that can be accompanied by other diseases. In recent years, with the increase in the lifespan of ...
This study included PsA patients who had peripheral joint involvement and, RA patients. Since PsA has a heterogeneous clinical picture, only patients with peripheral joint involvement were included in...
The sample of the study included 232 RA and 73 PsA patients. Polypharmacy was present at the treatment onset in 115 (49.6%) of the RA patients and 28 (38.4%) of the PsA patients. At the sixth month of...
Polypharmacy was present both at the time of diagnosis and in the treatment process in the RA and PsA patients, and the presence of polypharmacy at the beginning of the treatment was among the factors...
Polypharmacy presents an increasing therapeutic challenge for physicians managing patients with chronic kidney disease (CKD). However, there is a lack of consensus regarding the specific medication co...
A comprehensive search was conducted in relevant databases (PubMed, SCOPUS, Cochrane, and disease-specific databases) from 2000 to May 2022 to identify studies with polypharmacy threshold definitions ...
Following the screening of the search results, duplicate records and studies that did not meet the inclusion criteria were removed, resulting in a total of 18 studies included in this review. Among th...
This review indicates that a numerical threshold of ≥5 medications is commonly used to define polypharmacy in patients with CKD. Nevertheless, it remains uncertain whether a kidney-related polypharmac...
Lower urinary tract (LUT) symptoms are a common presentation of autonomic dysfunction in Parkinson's disease (PD). Symptoms significantly impact quality of life and are associated with worsening of mo...
Multimorbidity is one of the biggest challenges faced by modern medicine, especially when managing older patients who are also often taking multiple medications. Multimorbidity is influenced by social...
This cross-sectional observational study included 573 patients aged 65-74 with multimorbidity (≥3 diseases) and polypharmacy (≥5 drugs). Corresponding data was taken drawn from the Spanish MULTIPAP st...
Mean patient age was 69.7 years, 55.8% of patients were female, 59.7% belonged to low social classes (V, VI), a monthly income of €1051-€1850 predominated, and the median number of diseases in the sam...
Our findings describe associations between social determinants of health and quality of life in patients aged 65-74 years with multimorbidity and polypharmacy. More illnesses, female gender, a lower e...